Statistics for EV-103: Initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma

Total visits

views
EV-103: Initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma 67

Total visits per month

views
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0

File Visits

views
2019 ESMO Enfortumab and pembrolizumab in urothelial cancer.pdf 23